Risk of adverse events ‐ not reported · participants at risk of high altitude illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Risk of adverse events ‐ not reported · participants at risk of high altitude illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Risk of acute mountain sickness · participants at risk of high altitude illness
Magnesium citrate showed no clear difference in risk of acute mountain sickness compared with placebo (low certainty).
1 finding from 1 review
Risk of adverse events: Loose stools · participants at risk of high altitude illness
Magnesium citrate may leads to higher risk of adverse events: Loose stools compared with placebo (low certainty).
1 finding from 1 review
Risk of acute mountain sickness · participants at risk of high altitude illness
1 finding from 1 review
Incidence of acute mountain sickness (AMS)‐ Follow‐ up: From arrival to 24 hours later · participants at risk of high altitude illness
Acetazolamide probably leads to lower incidence of acute mountain sickness (AMS)‐ Follow‐ up: From arrival… compared with placebo (moderate certainty).
1 finding from 1 review
Incidence of acute mountain sickness (AMS)‐ Follow‐ up: From arrival to 24 hours later · participants at risk of high altitude illness
Dexamethasone showed no clear difference in incidence of acute mountain sickness (AMS)‐ Follow‐ up: From arrival… compared with placebo (low certainty).
1 finding from 1 review
Adverse events: General‐ Follow‐ up: From arrival to 24 hours later · participants at risk of high altitude illness
1 finding from 1 review
Adverse events: Paresthesias‐ Follow‐ up: From arrival to 24 hours later · participants at risk of high altitude illness
Acetazolamide may leads to higher adverse events: Paresthesias‐ Follow‐ up: From arrival to 24 hours… compared with placebo (low certainty).
1 finding from 1 review
Side effects or other adverse events · participants at risk of high altitude illness
Acetazolamide may leads to higher adverse events: side effects‐ Follow‐ up: From arrival to 24 hours… compared with placebo (low certainty).
1 finding from 1 review
Incidence of acute mountain sickness (AMS)‐ Follow‐ up: From arrival to 24 hours later · participants at risk of high altitude illness
Budesonide may leads to lower incidence of acute mountain sickness (AMS)‐ Follow‐ up: From arrival… compared with placebo (low certainty).
1 finding from 1 review
Side effects or other adverse events · participants at risk of high altitude illness
1 finding from 1 review
Intervention not reported
Typical antipsychotic vs placebo · critically ill adults with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Typical antipsychotics vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Atypical antipsychotics vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Statin (HMG‐CoA)vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Alpha2 agonist vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Opioid vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Typical antipsychotic vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Atypical antipsychotic vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review